Thiazepine‐Based Hybrids as Promising Anti‐Colon Cancer Agents: Design, Synthesis, Computational and In Vitro Screening
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202401550 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Mahesh D Vaghasiya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, S.V. National Institute of Technology, Surat, Gujarat, 395007, India. Hauptthemen laut MEDLINE: Thiazepines, Antineoplastic Agents, Drug Design, Drug Screening Assays, Antitumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Sardar Vallabhbhai National Institute of Technology in Surat, India, Banaras Hindu University, Maulana Abul Kalam Azad University of Technology in West Bengal, India.
Abstract (Originalsprache)
Novel thiazepine‐based hybrids (9 a – d) were designed and synthesized to create lead molecules with exceptional anti‐colon cancer efficacy. Analytical methods, including IR, NMR, and HR‐MS, characterized the synthesized compounds. The in vitro colorectal study was carried out to compare the biological activity of newly developed compounds with the computational data. The tested compounds induced cytotoxicity in HT‐29 cells for both 24 h and 48 h in a dose‐dependent manner. However, compound 9 a induced cytotoxicity at much higher concentrations compared to the rest of the compounds. 9 b and 9 c caused 50 % cell death (compared to the untreated cells) at a dose of ~50 μM and 40 μM in case of 24‐hour exposure, respectively. On the contrary, for 48 h exposure, both 9 b and 9 c induced 50 % cell death concerning untreated cells at a dose of around ~20 μM, whereas 9 d exhibited 50 % cell death at 5 μM in the case of 48 h exposure. In silico ADMET was also carried out to understand the pharmacokinetics and safety profiles of the drug candidates. We found some of the critical targets of these compounds, which eventually will be integral to exploring the mechanistic actions of these compounds in colon cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, S.V. National Institute of Technology, Surat, Gujarat, 395007, India.
- Department of Biotechnology, Maulana Abul Kalam Azad University of Technology, Haringhata, Nadia, West Bengal, 741249, India.
ORCID-Profile: Mahesh D Vaghasiya, Arindam Sain, Jigarkumar V Mendapara, Debdut Naskar, Premlata Kumari
Förderung
- Sardar Vallabhbhai National Institute of Technology in Surat, India
- Banaras Hindu University
- Maulana Abul Kalam Azad University of Technology in West Bengal, India
Zitieren
APA
Vaghasiya, M. D., Sain, A., Mendapara, J. V., Khamrai, D., Naskar, D., & Kumari, P. (2025). Thiazepine‐Based Hybrids as Promising Anti‐Colon Cancer Agents: Design, Synthesis, Computational and In Vitro Screening. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401550
Vancouver
Vaghasiya MD, Sain A, Mendapara JV, Khamrai D, Naskar D, Kumari P. Thiazepine‐Based Hybrids as Promising Anti‐Colon Cancer Agents: Design, Synthesis, Computational and In Vitro Screening. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202401550
BibTeX
@article{Vaghasiya2025,
author = {Vaghasiya, Mahesh D and Sain, Arindam and Mendapara, Jigarkumar V and Khamrai, Dipshikha and Naskar, Debdut and Kumari, Premlata},
title = {Thiazepine‐Based Hybrids as Promising Anti‐Colon Cancer Agents: Design, Synthesis, Computational and In Vitro Screening},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202401550}
}
EUVIMED